A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine
Clinical trial NCT06899802 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06899802
- Sponsor
- Bavarian Nordic
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-10
- Primary completion
- 2027-02-01
- Enrollment
- 411
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.